Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose anti-androgen drugs and certain drug combinations are effective for hirsutism, and insulin sensitizers show promise, especially for those with polycystic ovarian syndrome.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

A high dietary antioxidant index may lower the risk of various diseases, but more research is needed.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

PCOS is a long-term condition that needs more research for better understanding and treatment.

Botulinum toxin A can help improve thin endometrium and embryo implantation.

Spironolactone is effective for acne, hidradenitis suppurativa, female hair loss, and hirsutism but is underused in dermatology.

A higher testosterone to dihydrotestosterone ratio may indicate worse metabolic health in women.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Human hair follicle stem cells improve ovarian function in mice with damaged ovaries.

People with polycystic ovary syndrome (PCOS) are more likely to have higher levels of depression and anxiety, but their personality traits are similar to those without PCOS.

Hormone therapy may increase migraines in transgender women and decrease them in transgender men; more research is needed on migraine management in transgender individuals.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Neural networks can effectively predict hair loss.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

A patient with Werner syndrome showed a range of aging-like symptoms and metabolic issues, underscoring the need for early detection and treatment.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Women with PCOS have lower amylin levels, which are not related to their body weight.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

BeauTop improves hair growth in androgenetic alopecia patients.

Finasteride helps hair growth but may cause sexual side effects and depression.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.